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Abstract. 
 
Diacylglycerol kinase (DGK) is suggested to
attenuate diacylglycerol-induced cell responses through
the phosphorylation of this second messenger to phos-
phatidic acid. Here, we show that DGK
 
a
 
, an isoform
highly expressed in T lymphocytes, translocates from cy-
tosol to the plasma membrane in response to two differ-
ent receptors known to elicit T cell activation responses:
an ectopically expressed muscarinic type I receptor
and the endogenous T cell receptor. Translocation in
response to receptor stimulation is rapid, transient,
and requires calcium and tyrosine kinase activation.
DGK
 
a
 
-mediated phosphatidic acid generation allows
dissociation of the enzyme from the plasma membrane
and return to the cytosol, as demonstrated using a phar-
macological inhibitor and a catalytically inactive version
of the enzyme. The NH
 
2
 
-terminal domain of the protein
is shown to be responsible for receptor-induced trans-
location and phosphatidic acid–mediated membrane
dissociation. After examining induction of the T cell acti-
vation marker CD69 in cells expressing a constitutively
active form of the enzyme, we present evidence of the
negative regulation that DGK
 
a
 
 exerts on diacylglycerol-
derived cell responses. This study is the first to describe
DGK
 
a
 
 as an integral component of the signaling cas-
cades that link plasma membrane receptors to nuclear
responses.
Key words: diacylglycerol kinase • lymphocytes • T
cell activation • signal transduction • green fluorescent
protein
 
Introduction
 
The magnitude and specificity of cellular responses are
dictated by a delicate balance between positive and nega-
tive signals that are generated after receptor stimulation.
Although the mechanisms that promote the intracellular
generation of signals have been extensively analyzed,
those leading to negative regulation of signal generation
remain largely undefined. DAG kinase (DGK)
 
1
 
 generates
phosphatidic acid (PA) through the phosphorylation of
DAG. Since DAG is a well known lipid second messenger
that is rapidly generated in response to receptor stimulation,
DGK activation may be related directly to the termination
of DAG-derived signals. Nine different DGK isoforms have
thus far been cloned and their cDNA characterized.
Alignment of the different DGK sequences has allowed
identification of motifs that may be important for DGK
function and/or regulation (Topham and Prescott, 1999).
All isoforms contain a highly conserved catalytic domain
in the COOH-terminal region and a pair of cysteine-rich
motifs similar to those present in PKC but lacking certain
consensus residues present in phorbol ester–binding pro-
teins (Hurley et al., 1997). DGKs also exhibit structurally
different motifs, probably related to their regulation, which
have allowed their classification into five different families
(Van Blitterswijk and Houssa, 1999). Type I DGKs contain
a pair of EF hand-like domains in the NH
 
2
 
-terminal half of
the protein. Type II DGKs have a pleckstrin homology–like
domain, whereas type IV DGKs have COOH-terminal
ankyrin repeats and a region homologous to the phosphory-
lation site of the MARCKS protein. Type V DGK has three
instead of two cysteine-rich domains and a Ras-binding do-
main. Type III DGKs are the only enzymes that have no
domain with obvious regulatory functions. The presence of
a variety of domains with known regulatory properties to-
gether with the differential tissue expression pattern of the
isoforms suggests that regulation of this enzyme family
must vary among cell types or in response to different
stimuli. Although these enzymes are structurally well char-
acterized, an important remaining question is that of their
regulation by receptor-derived signals.
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Abbreviations used in this paper:
 
 BAPTA, 1,2-bis(aminophe-
noxy)ethane-
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,
 
N
 
,
 
N
 
9
 
,
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9
 
-tetraacetic acid; DGK, DAG kinase; DiC8, 1,2-
dioctanoyl 
 
sn
 
-glycerol; GFP, green fluorescent protein; IL, interleukin;
PA, phosphatidic acid; PBut, phosphatidylbutanol; PDBu, 1,2-dioleoyl-
glycerol, phorbol-12,13-dibutyrate; PE, phycoerythrin; PI4,5P
 
2
 
, phos-
phatidylinositol 4,5-bisphosphate; PLD, phospholipase D; SAX-HPLC,
strong ion exchange high performance liquid chromatography; TCR, T
cell receptor.
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DGK
 
a
 
 belongs to the type I DGK family and is abun-
dant in the cytosol of T lymphocytes (Sakane et al., 1991).
Here, we have studied the role of this enzyme in the regu-
lation of DAG-derived signals that control T cell acti-
vation events. T lymphocyte activation is triggered by
stimulation of the antigen receptor in concert with costim-
ulatory molecules through a complex signaling cascade,
in which increases in membrane DAG and cytosolic cal-
cium concentration are essential events (Kane et al.,
2000). The intracellular increase in these two second mes-
sengers is sufficient to elicit several T cell responses, as has
been shown by ectopic expression of other receptors that,
through PLC-regulated hydrolysis of phosphatidylinositol
4,5-bisphosphate (PI4,5P
 
2
 
), can lead to antigen-indepen-
dent T cell activation. A good example is the human mus-
carinic receptor (HM-1), which increases the intracellular
calcium concentration and membrane DAG in neurons
and effector cells through a G protein–coupled mecha-
nism. This receptor is functional when stably transfected in
the parental Jurkat T cell line (J-HM1-2.2) (Desai et al.,
1990). Stimulation of J-HM1-2.2 cells by carbachol, an
HM-1 agonist that has no effect on parental Jurkat cells,
induces several T cell responses such as expression of the
interleukin (IL)-2 receptor alpha chain, CD69, and Fas
ligand (Desai et al., 1990; Izquierdo et al., 1996). This indi-
cates that the stimulation of PI4,5P
 
2
 
 hydrolysis elicited by
this agonist can mimic antigen receptor–regulated events
in T lymphocytes. Whereas some responses require a more
complex set of receptor-derived signals, the expression of
the CD69 activation marker is strictly dependent on the el-
evation of DAG in the plasma membrane (Cebrián et al.,
1988). We have used this model in which receptor-induced
DAG increase is directly related to transcriptionally regu-
lated protein expression to study the role of DGK
 
a
 
 as a
modulator of receptor-derived cell responses. Our results
indicate that, in response to carbachol stimulation of
J-HM1-2.2 cells, DGK
 
a
 
 translocates rapidly from the cyto-
sol to the plasma membrane by a mechanism that requires
the NH
 
2
 
 terminus of the enzyme. This domain is also re-
sponsible for the dissociation of the enzyme from the
plasma membrane which takes place after PA generation.
Using a pharmacological inhibitor of the enzyme and plas-
mids encoding green fluorescent protein (GFP) fused to
the wild-type or a truncated DGK
 
a
 
, we demonstrate for
the first time the role of DGK
 
a
 
 in the negative regulation
of receptor-derived signals. DGK
 
a
 
 translocation is also in-
duced by T cell receptor (TCR) cross-linking, suggesting
that membrane localization of DGK
 
a
 
 is a general re-
sponse to receptor stimulation. Plasma membrane translo-
cation of DGK
 
a
 
 cannot be induced by addition of DAG
analogues but is mimicked by intracellular calcium eleva-
tion together with activation of tyrosine kinases, suggest-
ing that receptor-induced enzyme translocation of DGK
 
a
 
requires at least these two signals.
 
Materials and Methods
 
Reagents
 
Carrier-free [
 
32
 
P]orthophosphate and [
 
g
 
-
 
32
 
P]ATP were purchased from
Amersham Pharmacia Biotech. Silica gel thin layer chromotography
plates (60Å, LK6D) were from Whatman. R59949, 1,2-bis(aminophe-
noxy)ethane-
 
N
 
,
 
N
 
,
 
N
 
´,
 
N
 
´-tetraacetic acid (BAPTA), U73343, U73122,
and herbimycin were purchased from Calbiochem. 1,2-dioleoylglycerol,
phorbol-12,13-dibutyrate (PDBu), carbachol, 1,2-dioctanoyl 
 
sn
 
-glycerol
(DiC8), ionomycin, orthovanadate, and poly-
 
L
 
-lysine were from Sigma-
Aldrich. Radiolabeled standards for strong ion exchange high perfor-
mance liquid chromatography (SAX-HPLC) were prepared as described
previously (Jones et al., 1999). Anti-GFP monoclonal antibody was from
CLONTECH Laboratories, Inc. HRP-conjugated goat anti–mouse IgG
was from Dako, phycoerythrin (PE)-conjugated anti–human CD69 was
from PharMingen, and Cy3-goat anti–rabbit IgG was from Jackson Immu-
noResearch Laboratories.
 
Cell Culture
 
The J-HM1-2.2 cell line was generated by stable transfection of HM-1 in
the human leukemic Jurkat T cell line (Desai et al., 1990). Cells were
maintained in RPMI 1640 medium (Life Technologies). COS-7 cells
(American Type Culture Collection) were cultured in DME. Media were
supplemented with 10% FBS, 2 mM glutamine, 1 mM sodium pyruvate,
10 mM Hepes, and 100 
 
m
 
g/ml each of penicillin and streptomycin. Ba/F3
cells were maintained in complete RPMI medium supplemented with
10
 
2
 
5
 
 M 2-mercaptoethanol and 5% WEHI-3B–conditioned medium as a
source of IL-3.
 
Constructs and Transfection
 
The PEF-GFPC1 plasmid was generated by replacing the cytomegalovirus
promoter in the GFP-C1 plasmid (CLONTECH Laboratories, Inc.) with
the PEF-BOS promoter (donated by Dr. J.A. Garcia-Sanz, DIO/CNB,
Madrid, Spain). Full-length DGK
 
a
 
 and 
 
D
 
(1–192)DGK
 
a
 
 cDNAs sub-
cloned into PSRE plasmids have been described previously (Sakane et al.,
1996) and were given by Drs. F. Sakane and H. Kanoh (University of Sap-
poro, Sapporo, Japan). The cDNAs were excised from the PSRE plasmids
and subcloned into PEF-GFP-C1 using the EcoR1 site. The kinase-dead
version of GFP-DGK was generated replacing the Gly 432 in the catalytic
domain by Ala, using the Quickchange Site-directed Mutagenesis kit
(Stratagene). To target the GFP-DGK
 
a
 
 to the membrane, the GFP-
DGK
 
a
 
 NH
 
2
 
 terminus was modified by adding the pYes myristoylation se-
quence using specific primers flanked for restriction sites. The annealed
DNA fragment was fused in frame via the respective restriction sites to
the NH
 
2
 
 terminus of GFP in the GFP-DGK
 
a
 
 construct. For transfection,
cells in logarithmic growth were transfected with 25 
 
m
 
g of the correspond-
ing plasmid DNA by electroporation at 230 V/975 
 
m
 
F. Cells were analyzed
between 24 and 48 h after transfection.
 
In Vivo Generation of PA
 
When J-HM1-2.2 cells reached a density of 
 
z
 
10
 
6 
 
cells/ml, they were
washed twice in phosphate-free RPMI medium supplemented with 2 mM
glutamine and further incubated for 90 min. Metabolic labeling was per-
formed using 150 
 
m
 
Ci/ml [
 
32
 
P]orthophosphate for 1 h. Cells were then
challenged as indicated in the figure legends. When R59949 (10 
 
m
 
M) was
used, a 10-min preincubation was used before addition of carbachol. After
the indicated times, total cellular lipids were extracted and separated by
SAX-HPLC (Jones et al., 1999) or by TLC with a solvent system of 1-pro-
panol/2 M acetic acid (2:1 vol/vol) in the presence of phospholipid stan-
dards. After drying at room temperature, phospholipid migration on the
TLC plate was identified using iodine staining, and associated radioactiv-
ity was monitored in a Bio-Rad Laboratories PhosphorImager. When
phospholipase D (PLD) activity was determined by the transphosphatidyla-
tion reaction, experiments were performed as described above except that
cells were preincubated for 15 min in the presence of 1% 1-butanol before
carbachol stimulation. After total lipid extraction, PA and phosphatidyl-
butanol (PBut) were separated by TLC with a solvent system of ethyl ace-
tate/isooctane/acetic acid (9:5:2 vol/vol/vol).
 
Determination of DAG Levels
 
DAG generation was quantified according to a modification of the DAG
kinase assay (Preiss et al., 1986) as has been described previously (Flores
et al., 1998).
 
Measurement of DGK Activity
 
COS-1 cells were transfected with the indicated cDNA, harvested after 36–
48 h, washed twice with ice-cold PBS, and frozen at 
 
2
 
70
 
8
 
C. The cells were
thawed and lysed by nitrogen cavitation (10 min at 500 psi, 4
 
8
 
C) in a buffer
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containing 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 50 mM NaF, 2 mM
Na
 
3
 
VO
 
5
 
, 1 mM PMSF, and 10 
 
m
 
g/ml each of leupeptin and aprotinin. Ly-
sates were then centrifuged (800 
 
g
 
) and the supernatant was used to deter-
mine DGK activity, as described previously (Flores et al., 1996). At the end
of the phosphorylation assay, radiolabeled lipids were extracted, dried un-
der a nitrogen stream, dissolved in 20 
 
m
 
l of chloroform/methanol (2:1 vol/
vol), and applied to silica gel plates, with DiC18 PA as a standard. Plates
were developed with a solvent system consisting of chloroform/metha-
nol/4 M ammonia (9:7:2 vol/vol/vol). Dried plates were autoradiographed
and the bands corresponding to PA were quantified by phosphorimaging.
 
Analysis of CD69 Cell Surface Expression 
 
Cells were preincubated with vehicle or the DGK inhibitor R59949 for 10
min, then stimulated with carbachol or PDBu as indicated. CD69 expres-
sion on the cell surface was analyzed using a PE-conjugated anti–human
CD69 monoclonal antibody. Immunofluorescence intensity of the cells
was determined by flow cytometry (EPICS-XL; Beckman Coulter). The
CD69 expression level in transfected cells was analyzed 48 h after trans-
fection, gating for GFP-positive and -negative cells.
 
Immunoblotting
 
Cells were lysed in 1 ml of lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 5 mM sodium pyrophosphate, 1 mM Na
 
3
 
VO
 
4
 
, 1% Noni-
det P-40, 1 mM PMSF, and 10 
 
m
 
g/ml each aprotinin and leupeptin) for 30 min
on ice. After centrifugation (20,000 
 
g
 
, 10 min, 4
 
8
 
C), supernatants were ana-
lyzed by SDS-PAGE. Electrophoresed samples were transferred to nitrocel-
lulose and expression of the GFP-coupled constructs was analyzed using anti-
GFP antibody and the ECL detection kit (Amersham Pharmacia Biotech).
 
Immunofluorescence Microscopy
 
Cells were harvested 36 h after electroporation with the corresponding
plasmids, washed, and allowed to attach to poly-
 
L
 
-lysine–coated coverslips
(1 h, room temperature). Cells were treated as indicated (in corresponding
figure legends). Cells were fixed with 4% (wt/vol) paraformaldehyde in
PBS, washed twice with PBS, and analyzed by confocal microscopy (TCS-
NT; Leica). For visualization of endogenous DGK
 
a
 
, cells were stained with
anti-DGK
 
a
 
 antibody and with Cy3-goat anti–rabbit IgG. Samples were
fixed and permeabilized with 2% BSA plus 0.1% Triton X-100 in PBS. To
visualize the nuclei, cells were incubated with TOPRO-3 or Sylver Green
(1 
 
m
 
g/ml, 10 min) (Molecular Probes). For TCR and anti-CD28 stimula-
tion, slides were precoated with antibodies at a final concentration of 10
 
m
 
g/ml. After coating, slides were washed with PBS, and the cells were
seeded and centrifuged (80 
 
g
 
, 20 s). At the end of the times indicated, cells
were fixed with 4% (wt/vol) paraformaldehyde in PBS, washed twice with
PBS, and analyzed by confocal microscopy (TCS-NT; Leica).
 
Results
 
DGK Activity Regulates Expression of T Cell
Activation Markers
 
Carbachol stimulation of the Jurkat-derived J-HM1-2.2
cell line, which ectopically expresses the muscarinic type 1
receptor, has been shown previously to induce a rapid ele-
vation of inositol polyphosphates (Desai et al., 1990). We
confirmed that carbachol addition to this cell line also in-
duces the rapid and transient elevation of DAG, which
reaches maximal values 2–5 min after stimulation (data
not shown). These data suggest the existence of a mecha-
nism responsible for the removal of the generated DAG.
One enzyme that may perform this process is DGK, which
in doing so causes generation of PA. After carbachol stim-
ulation of J-HM1-2.2 cells, a rapid increase in the cellular
PA content could be detected, which by 2 min was more
than twice that of control values (Fig. 1 a). To assess
Figure 1. Carbachol induces DGK activation in
J-HM1-2.2 cells. (a) Generation of PA after carbachol
addition. Cells were metabolically radiolabeled with
[32P]orthophosphate and stimulated with vehicle or
carbachol (50 nM). At the times indicated, cells were
collected, total cellular lipids were extracted, and the
PA content was determined by SAX-HPLC analysis of
deacylated samples (see Materials and Methods). The
results are shown of a single experiment representative
of three independent experiments. (b) Effect of DGK
inhibition on PA generation. Cells were metabolically
radiolabeled with [32P]orthophosphate and stimulated
as indicated. After 2 min, total lipids were extracted,
and the PA generated was determined by TLC and
quantified as described in Materials and Methods.
The top of the figure represents a typical experiment,
showing the autoradiogram of the TLC plate corre-
sponding to the area of PA standard migration.
The quantification of the PA generated in three in-
dependent experiments is shown. (c) Effect of
DGK inhibition on DAG generation. Cells were
stimulated as indicated: control (C), carbachol
(CCh), and R59949 (R59). After 2 min, total lipids
were extracted and the level of DAG was quanti-
fied as described in Materials and Methods. The
quantification of the DAG measured in three inde-
pendent experiments is shown. (d–f) Effect of DGK
inhibition on CD69 expression. J-HM1-2.2 cells were
stimulated with vehicle (d), carbachol (e), or PDBu 1
ionomycin (f); after 6 h, cells were collected and CD69
expression was determined. Filled areas represent
CD69 expression by cells after treatment, and empty
areas represent cells pretreated with the DGK inhibitor
R59949 (10 mM, 10 min) before further stimulation.
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whether the increase in carbachol-stimulated PA produc-
tion was due to activation of a PLD, identical experiments
were performed in the presence of the primary alcohol
1-butanol. PLD is the only enzyme that catalyzes a transphos-
phatidylation reaction, diverting PA production to PBut.
No significant PBut accumulation was detected after 2 min
of carbachol stimulation. At later time points, only a small
percentage of PA (
 
z
 
20% of total) was converted to PBut
(data not shown). This indicates that the majority of PA is
generated via DGK. DGK-regulated PA generation in re-
sponse to carbachol was demonstrated further using the
specific type I DGK inhibitor R59949 (Jiang et al., 2000).
The rapid PA elevation detected 2 min after carbachol ad-
dition was blocked completely by preincubating cells with
R59949 before carbachol stimulation (Fig. 1 b). In con-
trast, PDBu and calcium ionophore treatment did not af-
fect the endogenous PA level, indicating that receptor-reg-
ulated DGK activation is not a downstream effect of PKC
activation. Accordingly, pharmacological inhibition of
DGK activity induced an elevation of the DAG level both
in control and carbachol-stimulated cells (Fig. 1 c).
Since the rapid PA increase appeared to be mediated by
DGK activation, the DGK requirement for DAG tran-
scriptionally regulated events was determined. In J-HM1-
2.2 cells, carbachol is a potent inducer of the early activa-
tion marker CD69 (Desai et al., 1990). Whereas the re-
quirements for other T cell–regulated responses are more
stringent, CD69 expression is mimicked by PDBu or DiC8
treatment of cells (Cebrián et al., 1988). This indicates that
transcriptional regulation of CD69 expression is directly
Figure 2. Carbachol-mediated plasma membrane translocation of GFP-tagged DGKa. (a) The drawing shows the GFP-DGKa con-
struct used in this study; the conserved cluster in the catalytic domain in which Gly432 was mutated is marked as a yellow dot. The
conserved motifs of the enzyme are indicated. (b) Analysis of carbachol-mediated plasma membrane translocation of GFP-tagged
DGKa. J-HM1-2.2 cells were transfected with either GFP-DGKa (top and middle) or a catalytically inactive form of the enzyme
(GFP-DGKa kD). After 48 h, cells were treated with vehicle or carbachol for the times indicated. In the middle panel, cells were pre-
treated with R59949 (10 mM, 10 min) before carbachol stimulation. Cells were fixed and GFP fluorescence was visualized by confocal
microscopy. TOPRO-3 was used to visualize nuclei.
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related to the rapid elevation of plasma membrane DAG
that occurs after receptor stimulation. The effect of phar-
macological inhibition of DGK activity on CD69 induction
by carbachol was subsequently studied. Pretreatment of
J-HM1-2.2 cells with R59949 induced an increase in CD69
expression, even in the absence of carbachol (Fig. 1 d).
R59949 inhibition of DGK activity also increased CD69
cell surface expression compared with that induced by car-
bachol alone (Fig. 1 e). On the contrary, DGK inhibition
had no effect on PDBu-induced CD69 expression (Fig. 1 f),
suggesting that DGK activity regulates receptor-induced
signals but lies upstream of PKC activation.
 
Localization of GFP-tagged DGK
 
a
 
 in Response
to Carbachol
 
Carbachol stimulates PA generation, and inhibition of
DGK activity results in increased DAG generation and
CD69 expression. These findings point to a model in which
DGK participates in the early signaling generated by the
receptor. Jurkat cells express high DGK
 
a
 
 levels, which
have been shown to be mostly cytosolic by subcellular
fractionation (Yamada et al., 1989). The recruitment of cy-
tosolic enzymes from cytosol to the plasma membrane is
usually a prerequisite for participation of intracellular
molecules in signal transduction after receptor stimula-
tion. If DGK is the enzyme responsible for the rapid clear-
ance of the DAG generated in the plasma membrane, it
must translocate after carbachol stimulation. To study the
effect of carbachol on subcellular DGK
 
a
 
 redistribution,
we generated a plasmid encoding the cDNA for DGK
 
a
 
fused to GFP (Fig. 2 a). The GFP-tagged DGK
 
a
 
 fluores-
cence in unstimulated cells corresponded to a cytosolic en-
zyme, as described for endogenous DGK
 
a
 
 (Flores et al.,
1999) (Fig. 2 b, top). Carbachol addition resulted in the
rapid and transient enzyme translocation from cytosol to
the plasma membrane, which was detected as early as 2
min after stimulation; by 10 min after stimulation, the ma-
jority of the enzyme had returned to the cytosol. At later
times, even at 1 h after receptor stimulation, a fraction of
the enzyme was again found in the plasma membrane. Pre-
treatment of unstimulated cells with the DGK inhibitor
R59949 did not affect the cytosolic localization of GFP-
DGK
 
a
 
 (Fig. 2 b, middle); nonetheless, R59949 completely
prevented dissociation of the enzyme from the plasma
membrane after carbachol addition. When cells were pre-
treated with the inhibitor, carbachol-induced DGK trans-
location was complete and lasted for 
 
$
 
1 h after receptor
stimulation (Fig. 2 b, middle).
Inhibition of DGK activity prevented enzyme dissocia-
tion from the plasma membrane. To determine whether
this effect was directly related to enzyme activity, we ex-
amined the membrane localization of a catalytically inac-
tive DGK
 
a
 
 fused to GFP. Rapid translocation of the inac-
tive mutant was detected in response to carbachol (Fig. 2
b, bottom). Nevertheless, as was the case after inhibitor
treatment, the kinase-dead DGK
 
a
 
 remained at the mem-
brane at all the times examined.
 
GFP-DGK
 
a
 
 Behaves Similarly to Endogenous DGK
 
a
 
To determine whether GFP-tagged DGK
 
a
 
 responded to
carbachol stimulation as did the endogenous enzyme, we
analyzed the cells using a specific antibody shown to recog-
Figure 3. Carbachol-mediated plasma
membrane translocation of endogenous
DGKa. J-HM1-2.2 cells were treated
with vehicle or carbachol for 2 min as in
the legend to Fig. 2. In the bottom panel,
cells were pretreated with R59949 (10
mM, 10 min) before carbachol stimula-
tion. Cells were fixed and fluorescence
was visualized by confocal microscopy.
Nuclei were visualized by staining with
Sylver green.
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nize endogenous DGK
 
a
 
 in T lymphocytes (Yamada et al.,
1989; Flores et al., 1996). After carbachol addition, there
was partial translocation of the cytosolic enzyme to the
plasma membrane within 2 min (Fig. 3). Again, R59949
pretreatment of cells did not alter cytosolic localization of
the enzyme, but it did greatly enhance DGK
 
a
 
 redistribu-
tion to the plasma membrane. These results confirm that
transfected GFP-tagged DGK
 
a
 
 behaves as does the en-
dogenous enzyme, providing a useful tool to examine pro-
tein translocation in response to receptor stimulation.
 
The DGK
 
a
 
 NH
 
2 
 
-terminal Domain Contains a Negative 
Regulatory Site
 
The DGK
 
a
 
 NH
 
2
 
-terminal domain contains a pair of EF
hand motifs found in a large number of functionally di-
verse Ca
 
2
 
1
 
-binding proteins (Sakane et al., 1990). To study
the role of this domain in carbachol-induced DGKa trans-
location, we generated a plasmid encoding the GFP pro-
tein fused to a DGKa truncation mutant, in which the first
192 NH2-terminal amino acids, including the EF hand do-
Figure 4. Deletion of the NH2-terminal domain of DGKa increases its enzymatic activity and allows constitutive localization in the
plasma membrane. (a) COS-7 cells were transfected with vectors encoding GFP, GFP-DGKa, or GFP–D(1-192)DGKa. At 48 h after
transfection, expressed proteins were analyzed by Western blotting with an anti-GFP antibody. (b) Deletion of the EF hand motif induces
increased enzymatic activity. DGK activity of the expressed proteins was measured in total lysates of COS-7 cells 48 h after transfection.
Radiolabeled PA generated during the reaction was analyzed by TLC and quantified as described in Materials and Methods. The top
panel shows an autoradiogram of the TLC plate, and quantification of radioactivity incorporated into PA is shown (bottom). Three inde-
pendent experiments were performed with similar results. (c) Subcellular distribution of wild-type GFP-DGKa. J-HM1-2.2 (top) and Ba/
F3 (bottom) cells were transfected with the GFP-DGKa plasmid. (d) Deletion of the EF hand motif induces constitutive localization to
the plasma membrane. J-HM1-2.2 (top) and Ba/F3 (bottom) cells were transfected with the GFP–D(1-192)DGKa plasmid. GFP fluores-
cence was determined by confocal microscopy of cells 48 h after transfection. Nuclei were visualized by staining with TOPRO-3.
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main, are deleted. DGKa bearing a deletion of the EF
hand domain is described to have higher activity than the
wild-type enzyme (Sakane et al., 1996). Fusion of the GFP
tag to this truncated construct did not alter its characteris-
tics. Transfection of both constructs in COS-7 cells gener-
ated proteins of the expected molecular weights, both of
which were expressed to a similar extent (Fig. 4 a); none-
theless, the enzyme bearing the NH2-terminal truncation
was far more active than its wild-type counterpart (Fig. 4
b). When J-HM1-2.2 cells were transfected with the dele-
tion mutant, a striking difference was found in the subcel-
lular localization of the protein compared with that of the
wild-type enzyme (Fig. 4 c, top). GFP–D(1-192)DGKa was
constitutively associated with the plasma membrane, even
in the absence of carbachol (Fig. 4 d, top). This suggests
that the NH2-terminal domain, deleted in this construct,
exerts a negative regulatory role, maintaining the enzyme
in the cytosol in the absence of receptor signaling and also
allowing its dissociation from the plasma membrane after
PA generation. Constitutive membrane localization of the
GFP–D(1-192)DGKa construct is not exclusive of T cells,
since a similar distribution was detected after transfection
of the pre-B murine cell line Ba/F3 (Fig. 4, c and d, bot-
tom). To further evaluate the effect of expression of the
different constructs on DGK activity, cells were sorted af-
ter transfection to enrich the GFP-positive population. PA
formation was measured both in basal conditions and after
2 min of carbachol addition. We consistently found a
threefold increase in PA levels in cells expressing wild-
type DGKa compared with control cells. When the same
experiment was performed in cells expressing the GFP–
D(1-192)DGKa, PA elevation was more than fivefold
compared with that measured in GFP-transfected cells
(data not shown).
Membrane Localization of DGKa Attenuates
CD69 Expression
To examine the effect of DGK activity on carbachol-
induced CD69 expression, J-HM1-2.2 cells were transfected
with control GFP, GFP-DGKa, or GFP–D(1-192)DGKa.
GFP expression allowed us to determine for each trans-
fected cDNA CD69 surface expression in cells expressing
high levels of the transfected proteins, compared with GFP-
negative cells. Carbachol-induced CD69 expression was not
Figure 5. Constitutive membrane localization of GFP–D(1-192)DGKa correlates with reduced cell surface CD69 expression. (a) J-HM1-
2.2 cells were transfected with plasmids encoding GFP, GFP-DGKa, or GFP–D(1-192)DGKa plasmids. At 48 h after transfection, cells
were left untreated or stimulated with carbachol. CD69 expression was determined by flow cytometry 6 h after carbachol addition to the
cells. Histograms show GFP fluorescence (y-axis) plotted versus CD69 expression of control (left) and carbachol-treated (right) cells. (b)
Analysis of CD69 expression in GFP-negative versus GFP-positive cells. The CD69 level was determined in the different cell populations
after transfection by gating for GFP-negative and GFP-positive cells. CD69 expression in untransfected cells is represented by empty
areas and in GFP-positive cells by filled areas. The results shown are from a single experiment representative of three performed with
similar results.
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altered in GFP-expressing cells compared with GFP-nega-
tive cells (Fig. 5 a, top). A slight decrease on CD69 expres-
sion in the GFP population was detected when cells were
transfected with the GFP-DGKa construct (Fig. 5 a, mid-
dle). This indicates that the regulation exerted by carbachol
on DGKa translocation to the plasma membrane remained
effective. Nevertheless, when cells were transfected with the
GFP–D(1-192)DGKa construct, which has higher enzy-
matic activity and is constitutively located in the plasma
membrane, CD69 expression was significantly reduced
compared with that of untransfected cells (Fig. 5 a, bottom).
Moreover, there was an inverse correlation between GFP–
D(1-192)DGKa expression levels and CD69 cell surface
protein levels (Fig. 5 b). These results indicate that constitu-
tive plasma membrane localization of DGKa attenuates
CD69 expression in response to this ligand.
To further demonstrate that membrane localization of
DGKa mediated the reduction of CD69 expression, a
myristoylation signal sequence was added to the NH2-ter-
minal end of the GFP-DGKa construct to induce constitu-
tive association of this protein to the plasma membrane.
After transfection of this construct, cells were stimulated
with carbachol and CD69 expression in GFP-negative and
-positive gated cells was assessed. As is shown in Fig 6 a,
constitutive plasma membrane localization of DGKa se-
verely reduces CD69 expression compared with the wild-
type enzyme and behaves similarly to the truncated GFP-
DGKD192 mutant. A comparison of CD69 levels in cells
expressing DGKa versus those in cells expressing mem-
brane-associated enzyme further confirms that membrane
localization of DGKa has a dramatic effect on the down-
regulation of this activation marker. Finally, to demon-
Figure 6. Membrane localization of DGKa corre-
lates with reduced cell surface CD69 expression,
whereas lack of enzyme activity enhances CD69
expression. (a) J-HM1-2.2 cells were transfected
with plasmids encoding GFP, GFP-DGKa, GFP-
DGKa–Kd, GFP–D(1-192)DGKa, or Myr-GFP-
DGKa plasmids. At 48 h after transfection, cells
were left untreated or stimulated with carbachol.
CD69 expression was determined by flow cy-
tometry 6 h after carbachol addition to the cells.
Histograms show carbachol-induced CD69 expres-
sion in GFP negative (gray bars) and GFP positive
(black bars) after transfection of the different
constructs. Results shown are representative of a
single experiment of two performed with similar
results. (b) The cartoon shows the different GFP-
DGKa constructs used in these experiments.
Figure 7. Effect of TCR/CD28 cross-linking on
the subcellular redistribution of GFP-tagged
DGKa. J-HM1-2.2 cells were transfected with
GFP-DGKa and after 48 h, were seeded onto slides
precoated with anti-CD3 and anti-CD28 antibodies
and centrifuged for 20 s at 500 rpm. After incubation
for the times indicated, cells were fixed and GFP
fluorescence was visualized by confocal microscopy.
In the bottom panel, cells were pretreated with
R59949 for 10 min before layering onto the slides.
TOPRO-3 was used to visualize nuclei.
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strate the relevance of DGK activity in the control of
DAG-regulated responses, expression of CD69 was exam-
ined in cells expressing the GFP-tagged, kinase-dead ver-
sion of the enzyme. As shown in Fig. 6 a, CD69 expression
after carbachol treatment was higher in GFP-positive cells
compared with the GFP-negative ones. The effect on
CD69 expression after transfection of the kinase-dead mu-
tant was similar to that observed after pharmacological in-
hibition of DGK activity (Fig. 1 e). These results suggest
that overexpression of the kinase-dead mutant has a domi-
nant negative effect over the wild-type enzyme.
GFP-DGKa Translocates to the Membrane after
TCR/CD28 Cross-linking
We analyzed whether, in addition to carbachol, a more
physiological stimulus could also induce DGKa transloca-
tion. For this, we examined redistribution of GFP-tagged
DGKa in J-HM1-2.2 cells after anti-CD3 and anti-CD28
antibody cross-linking, which resembles the physiological
mechanism of T cell activation (Grakoui et al., 1999). Af-
ter TCR and CD28 triggering, there was partial transloca-
tion of the enzyme. As observed previously, pretreatment
of cells with the DGK inhibitor caused complete subcellu-
lar redistribution of the enzyme from cytosol to the plasma
membrane (Fig. 7). These results indicate that DGKa
translocation after receptor triggering is a general re-
sponse to both G protein– and tyrosine kinase–coupled re-
ceptors, confirming the role of DGKa in the regulation of
DAG-based signals.
Tyrosine Kinase Activation Is Required for
GFP-DGKa Translocation
Translocation of GFP-DGKa occurs very rapidly in re-
sponse to two alternative receptors known to activate ei-
ther PLCg or PLCb, suggesting DAG- and/or calcium-
dependent regulation of DGKa. PDBu and ionomycin
treatment of GFP-DGKa–transfected cells did not induce
enzyme translocation (not shown), thereby excluding
PKC- and/or calcium-dependent mechanisms. Unchanged
subcellular localization of the transfected GFP-DGKa
correlated with no increase in endogenous PA (Fig. 1 b).
This further confirmed that endogenous DGKa is not acti-
vated/translocated by PKC-dependent signals. We then
evaluated whether GFP-DGKa translocation, although
independent of PKC activation, was directly mediated
through PLC-mediated generation of second messengers.
Extracellular addition of DiC8, a DAG analogue with
short fatty acid chains, did not induce GFP-DGKa translo-
cation to the plasma membrane (Fig. 8 a). No transloca-
tion was detected after ionomycin treatment, either alone
(Fig. 8 b) or in combination with DiC8 (Fig. 8 c). The same
results were obtained when the cells were pretreated with
the DGK inhibitor R59949 to stabilize the plasma mem-
brane localization of the enzyme, which would exclude the
existence of very rapid and/or transient translocation after
calcium and/or DAG increase (data not shown). GFP-
DGKa translocation apparently required a receptor-
derived signal independent of those generated after PLC ac-
tivation. Cell surface receptors that lack intrinsic tyrosine
kinase activity, such as the antigen TCR, are known to ini-
tiate their actions by recruiting nonreceptor tyrosine ki-
nases (Kane et al., 2000); recent data suggest that G pro-
tein–coupled receptors function in an analogous manner
(Luttrell et al., 1999). Moreover, DGKa has been shown
to be a direct substrate of the EGF receptor in vivo
(Schaap et al., 1993). We therefore studied the role of ty-
rosine kinase activation in the translocation of GFP-
DGKa. Induction of tyrosine kinase activity in the trans-
fected cells had no apparent effect either alone (Fig. 8 d)
or combined with extracellular addition of DiC8 (Fig. 8 e).
Nonetheless, activation of tyrosine kinases together with
an increase in intracellular calcium concentration clearly
induced redistribution of the enzyme from the cytosol to
the plasma membrane (Fig. 8 f). In agreement with these
data, carbachol-induced translocation of GFP-DGKa
(Fig. 9 a) was prevented by pretreatment of transfected
cells with the PLC inhibitor U-73122 (Fig. 9 b) or with the
calcium chelator BAPTA (Fig. 9 c), indicating that cal-
cium signals, although not sufficient, are necessary for
Figure 8. Plasma membrane translocation
of GFP-tagged DGKa requires tyrosine
kinase activation and intracellular cal-
cium increases. J-HM1-2.2 cells were
transfected with GFP-DGKa. After 48 h,
the subcellular distribution of the enzyme
was determined by confocal microscopy
analysis of the cells after 2 min of the
following treatments: (a) DiC8 (100 mg/
ml); (b) ionomycin (1 mM) 1 calcium (2
mM) in the extracellular buffer; (c) DiC8 1
ionomycin/calcium; (d) H2O2 (2 mM) 1
sodium orthovanadate (1 mM); (e)
H2O2, sodium orthovanadate, and DiC8;
and (f) H2O2, sodium orthovanadate,
and ionomycin/calcium.
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DGKa recruitment to the plasma membrane. Finally, en-
zyme translocation in response to carbachol was blocked
by pretreatment of the cells with the tyrosine kinase inhib-
itor herbimycin A (Fig. 9 d). This inhibitor is known to in-
terfere with early T cell signaling events by inhibiting lck
and ZAP-70 functions, although it does not prevent the
carbachol-induced calcium increase (Graber et al., 1992).
Calcium generation together with activation of tyrosine ki-
nases are required to provide the signals necessary for re-
ceptor-induced translocation of DGKa.
Discussion
DAG phosphorylation by DGK to generate PA has long
been considered an intermediate step in the resynthesis of
phosphatidylinositol, with no specific role in the transduc-
tion of receptor-derived signals. Nonetheless, several re-
cent studies have suggested a role for DGK in the regula-
tion of cell responses elicited by external stimuli. DGKs
are encoded by a large gene family conserved throughout
phylogeny. This suggests that, as shown for other enzymes
involved in signaling such as PKC, PLC, or phosphatidyl-
inositide kinases, this is an extended family that shares
common enzymatic activity. The simplest explanation for
the existence of multiple DGK isoforms is that of redun-
dancy in their actions. Notwithstanding, the differences in
the regulatory domains of the various subtypes, together
with the dissimilar expression pattern in multiple tissues
for each isoform, indicate that the various DGK isoforms
serve distinct although related functions. DGKa was the
first enzyme of this family to be purified and have its
cDNA cloned (Sakane et al., 1990). The first hint of a role
for DGKa in the control of T cell responses was suggested
by the activation of this enzyme in response to IL-2, the
main T cell growth factor, and the demonstration that this
activity is necessary for coordinated transition of T cells
from late G1 to the S phase of the cell cycle (Flores et al.,
1996, 1999). These results indicated that activation of
DGKa correlated with receptor-regulated signals and sug-
gested a functional role for this enzyme in T cell response
control. Binding of IL-2 to its high affinity plasma mem-
brane receptor does not, however, cause an appreciable in-
crease in DAG levels. As we have shown, PA is generated
rapidly in response to IL-2 through the phosphorylation of
a preexisting DAG pool in the cells (Jones et al., 1999).
T lymphocytes express high DGKa levels in cytosol, and
the possibility that this enzyme has a role in the DAG
downregulation generated in response to receptor stimula-
tion remained to be investigated. In this study, we have
demonstrated that DGKa translocates to the plasma
membrane in response to two alternative receptor path-
ways known to promote T cell activation responses.
DGKa translocation is induced through stimulation of an
ectopically expressed, G protein–coupled muscarinic type
1 receptor that exerts its actions through activation of
PLCb. Our results demonstrate that DGKa translocates
to the plasma membrane in response to receptor stimula-
tion and that membrane localization of DGKa is directly
related to the attenuation of transcriptionally regulated
DAG-derived responses, such as CD69 cell surface ex-
pression. Moreover, translocation takes place in response
to a more physiological stimulus such as TCR cross-link-
ing, where DAG is also generated from PI4,5P2 through
activation of the PLCg isoform. All together, these results
indicate that receptor-stimulated DGKa activation is a
general feature responsible for regulation of the cellular
DAG level generated through PI4,5P2 hydrolysis, a role
that has been suggested but never directly demonstrated.
Here, we show that the plasma membrane localization
of DGKa is tightly regulated by receptor-derived signals,
where tyrosine kinase activation after receptor occupancy
seems to be essential for receptor-induced translocation.
Moreover, membrane localization is regulated by enzyme
activity, suggesting that PA generation releases the en-
zyme from the membrane back to the cytosol. Experi-
ments with the myristoylated form of the enzyme indicate
that, although enzymatic activity regulates subcellular lo-
calization, the contrary is also true since targeting of the
enzyme to the membrane appears to be sufficient to main-
tain the protein in an active conformation. Those results
further confirm the close correlation between membrane
localization and enzyme activity and indicate that the
more important aspect when studying the physiological
regulation of this enzyme by different stimuli should be
that of its subcellular localization. This study also allows us
to draw some important conclusions on the role of the dif-
ferent DGKa domains in the control of its subcellular
distribution in response to receptor activation. We dem-
onstrate the negative regulatory role of the DGKa NH2-
terminal domain not only by examining enzymatic activity
but also by analyzing the subcellular localization of the
truncated protein. Deletion of the NH2-terminal domain
increases enzymatic activity and induces constitutive local-
ization of the enzyme to the plasma membrane in both
Jurkat and Ba/F3 cells, suggesting that DGKa association
Figure 9. Pharmacological inhibition of calcium generation and
tyrosine kinase activation prevents carbachol-induced transloca-
tion of DGKa. Cells were carbachol-stimulated for 2 min after
pretreatments with vehicle (a), PLC inhibitor U73122 (10 mM) (b),
BAPTA (50 mM) (c), and herbimycin (1 mg/ml) (d). TOPRO-3
was used to visualize nuclei.
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with the plasma membrane does not require receptor-gen-
erated signals, including DAG generation. A model can be
envisaged in which the DGKa NH2-terminal domain is
necessary to prevent membrane interaction, maintaining
the enzyme in a cytosolic/inactive conformation unless
modified by receptor-derived signals to an active/mem-
brane-bound conformation. The type I DGK NH2-termi-
nal domain is characterized by two EF hand motifs, a
helix-loop-helix structure, found in a large number of
functionally unrelated calcium-regulated proteins (Ikura,
1996). In many of these proteins, calcium binding induces
a conformational change in the EF hand motif, leading to
activation or inactivation of target proteins. DGKa puri-
fied from thymus cytosol binds calcium with an apparent
Kd of 0.3 mM (Sakane et al., 1991). The simplest model for
DGKa activation is that in which increases in cytosolic cal-
cium that follow receptor ligation induce a “closed-to-
open” conformational transition of the enzyme, allowing
interaction of the COOH-terminal domain with the mem-
brane. Our experiments nonetheless indicate that cytosolic
calcium elevation, although necessary, is not sufficient
even in combination with DAG to induce enzyme translo-
cation. Our results suggest the existence of a more com-
plex model in which activation of tyrosine kinases, trig-
gered by receptor occupancy, would also participate in
DGKa activation/translocation. These data concur with
previous studies in which it was shown that DGKa was ty-
rosine phosphorylated after EGF stimulation (Schaap et
al., 1993). The physiological function of this phosphoryla-
tion was not determined, although the authors suggested
that tyrosine phosphorylation may play a role in DGKa
association with the receptor. We do not detect tyrosine
phosphorylation of the enzyme either in response to re-
ceptor stimulation or after truncation of the NH2-terminal
domain, suggesting a more complex mechanism of enzyme
regulation, possibly through interaction with some adap-
tor-like protein. Activation of src-family tyrosine kinases
has very recently been described as necessary for hepato-
cyte growth factor–induced DGKa activation in endothe-
lial cells (Cutrupi et al., 2000). Although the subcellular lo-
calization of the enzyme is not examined in those studies,
the authors report a direct correlation between activation
of src-family kinases and DGKa activation by an unde-
fined mechanism. As is the case in our studies, hepatocyte
growth factor–induced DGKa activation does not induce
DGKa phosphorylation on tyrosine residues.
Plasma membrane translocation of GFP-DGKa in re-
sponse to receptor stimulation is rapid and reversible.
Nevertheless, a considerable amount of enzyme is still
plasma membrane bound even at 1 h after receptor stimu-
lation. This indicates that receptor-mediated translocation
is not sustained, as has been found for the in vivo translo-
cation of certain PKC isoforms in response to physiologi-
cal stimuli (Sakai et al., 1997). Carbachol-induced translo-
cation of GFP-DGKa is no longer reversible in the
presence of the DGK inhibitor R59949. Similar results are
obtained with a catalytically inactive form of the enzyme,
suggesting that local PA generation is necessary for en-
zyme release from the plasma membrane. This implies the
existence of a feedback mechanism in which the enzymatic
reaction product releases the enzyme from the membrane.
The truncated enzyme form, which has higher activity than
the wild-type, is insensitive to this feedback regulatory
mechanism since it is constitutively located in the plasma
membrane. This indicates that the deleted NH2-terminal
domain, which allows translocation in response to recep-
tor-derived signals, is also responsible for enzyme dissocia-
tion from the plasma membrane in response to high local
PA generation. In this regard, in vitro experiments dem-
onstrate that the NH2-terminal domain of DGKa is re-
sponsible for the regulation of enzyme activity by PA and
other acidic lipids (our unpublished results). Generation
of PA is suggested to have a significant role in protein re-
distribution from cytosol to the membrane, as proposed
for Rac release from RhoGDI (Tolias et al., 1998) or asso-
ciation of the NADPH oxidase complex (Erickson et al.,
1999). In this study, we propose a novel role for PA in the
regulation of DGKa membrane localization.
This study demonstrates that subcellular translocation is
an important mechanism in the control of DGKa. Plasma
membrane localization DGKa is tightly regulated not only
by receptor-derived signals but also by its own enzymatic
activity. Studies by us and other authors have indicated the
existence of different subcellular localizations for this and
other isoforms, suggesting that DGKs may phosphorylate
different DAG pools in distinct subcellular compartments
(Flores et al., 1996; Houssa et al., 1999; Topham et al.,
1998; Shirai et al., 2000). DGKz, for instance, is found in
the nucleus and translocates to the cytosol through a PKC-
dependent mechanism (Topham and Prescott, 1999). This
translocation is proposed to be necessary for the regulated
elevation of nuclear DAG during cell division.
DAG generated after receptor activation is responsible
for the binding and subsequent activation of classical and
novel PKCs and other proteins with phorbol ester–sensi-
tive domains such as unc-13 and chimerins (Oancea et al.,
1998). Cell fractionation studies also indicate the existence
of local DAG generation in the nucleus and other internal
membranes (Divecha et al., 1991; Nishizuka, 1992). The
regulated targeting of different DGKs to the plasma mem-
brane and other intracellular sites must be considered a
novel mechanism to regulate the spatiotemporal differ-
ences in DAG signaling for different receptors and/or cell
types. The genetic analysis of DGK deficiency in Dro-
sophila and Caenorhabditis elegans is currently helping to
elucidate the role of this enzyme as an essential compo-
nent of distinct receptor-regulated events. The most se-
vere Drosophila retinal degeneration mutant is generated
by mutations in the rdg-A gene, which encodes an eye-spe-
cific DGK isoform essential for maintaining subrrabdho-
meric structures in the retina (Masai et al., 1993). A recently
discovered DGK isoform (DGKi) expressed in human
brain and retina has 49% identity with rdgA and maps to a
known locus of inherited retinitis pigmentosa (Ding et al.,
1998). The C. elegans dgk-1 gene codes for a protein-regu-
lating acetylcholine release at neuromuscular junctions, at-
tenuating the effects of serotonin on synaptic transmission
(Nurrish et al., 1999). A general model can be conceived in
which distinct DGK isoforms coupled to different recep-
tors provide a mechanism of DAG consumption. This
would act in concert with pathways that lead to the gener-
ation of this second messenger, guaranteeing the strict
control of DAG-regulated responses such as CD69 cell
surface expression in the model we studied (Fig. 10).
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The magnitude, duration, and frequency of activation of
a signaling pathway exert a major influence on the cellular
response, which in turn demands that attention be paid to
the various control mechanisms that attenuate these sig-
nals. Our studies indicate that DGKa is another player in
the generation of the complex scaffold of signaling pro-
teins that locate to the plasma membrane in response to
receptor activation. A better knowledge of the role of
DGKa in the termination and propagation of the signals
generated after triggering of plasma membrane receptors
will be the object of future studies.
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